Canaccord Genuity Maintains Buy on GH Research, Raises Price Target to $31
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Sumant Kulkarni maintains a Buy rating on GH Research (NASDAQ:GHRS) and raises the price target from $30 to $31.

May 06, 2024 | 5:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Canaccord Genuity analyst Sumant Kulkarni reaffirmed a Buy rating on GH Research and increased the price target from $30 to $31.
The increase in price target by a reputable analyst like Sumant Kulkarni suggests a positive outlook on GH Research's stock, likely due to anticipated performance improvements or market conditions favoring the company. This endorsement could lead to increased investor confidence and a potential short-term price increase.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100